Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines
作者机构:Department of Internal MedicineKorea University College of MedicineSeoulRepublic of Korea Asia Pacific Influenza InstituteKorea University College of MedicineSeoulRepublic of Korea Vaccine Innovation CenterKorea University College of MedicineSeoulRepublic of Korea Department of Biomedical Systems InformaticsYonsei University College of MedicineSeoulRepublic of Korea Department of Food and NutritionChungbuk National UniversityCheongjuRepublic of Korea Department of Internal MedicineChungbuk National University HospitalCheongjuRepublic of Korea Medical Science Research CenterKorea University College of MedicineSeoulRepublic of Korea
出 版 物:《Signal Transduction and Targeted Therapy》 (信号转导与靶向治疗(英文))
年 卷 期:2023年第8卷第6期
页 面:2447-2450页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) the Basic Science Research Program through the NRF funded by the Ministry of Education a grant from the Ministry of Food and Drug Safety under Grants
主 题:vaccines respiratory acute
摘 要:Dear Editor,Coronavirus disease 2019(COVID-19)is a novel respiratory infectious disease,caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),which led to a global *** vaccination is the best measure to overcome a pandemic,the immunogenicity of vaccines can be influenced by diverse factors,including intrinsic(age,sex,genetics,and comorbidities),extrinsic(diet,nutrition,and behavior),and vaccine-associated characteristics.